Untargeted metabolomics reveals a new mode of action of pretomanid (PA-824)
Sign Up to like & getrecommendations! Published in 2018 at "Scientific Reports"
DOI: 10.1038/s41598-018-23110-1
Abstract: Pretomanid is a promising anti-tubercular drug currently at clinical phase III, but its mechanisms of action are currently unclear. This study aimed to: (i) reveal the metabolome of Mycobacterium smegmatis under pretomanid treatment; (ii) compare… read more here.
Keywords: pretomanid; metabolomics reveals; pretomanid treatment; reveals new ... See more keywords